MANGROVE PARTNERS IM, LLC - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 93 filers reported holding SEELOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
MANGROVE PARTNERS IM, LLC ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$3,478,000
-32.4%
2,133,4360.0%0.21%
-55.0%
Q3 2021$5,142,000
-8.7%
2,133,4360.0%0.46%
-20.7%
Q2 2021$5,632,000
-47.8%
2,133,436
-1.3%
0.58%
-46.7%
Q1 2021$10,791,0002,162,5431.09%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
GENDELL JEFFREY L 4,933,024$4,133,0000.30%
ACUTA CAPITAL PARTNERS, LLC 295,896$248,0000.12%
Connacht Asset Management LP 231,551$194,0000.10%
Uniplan Investment Counsel, Inc. 1,564,605$1,310,0000.08%
AdvisorShares Investments LLC 358,796$301,0000.05%
1492 Capital Management LLC 99,819$84,0000.04%
Woodline Partners LP 2,803,230$2,349,0000.04%
Ikarian Capital, LLC 257,883$215,0000.03%
Sovereign Financial Group, Inc. 75,000$63,0000.02%
Aquatic Capital Management LLC 6,400$5,0000.01%
View complete list of SEELOS THERAPEUTICS INC shareholders